Recent Quarter Total Invested
$111.10 M
Recent Quarter Institutional Ownership Percentage
70.43%
Total Invested of Last Quarter
$114.33 M
Ownership Percentage of Last Quarter
103.78%
Context Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 7.42 M | $14.54 M | 0.00% | 9.22% |
| NEXTECH INVEST LTD. | 11/14/2024 | 7.42 M | $14.54 M | 0.00% | 9.22% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 7.42 M | $14.54 M | -0.03% | 9.22% |
| GREAT POINT PARTNERS LLC | 11/13/2024 | 6.93 M | $13.59 B | -6.53% | 8.62% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 5.41 M | $10.61 M | 4.84% | 6.72% |
| BLACKSTONE INC. | 11/14/2024 | 2.44 M | $4.78 M | 32.72% | 3.03% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.94 M | $3.79 M | 0.00% | 2.40% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 1.85 M | $3.69 M | 100.00% | 2.30% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 1.76 M | $3.44 M | -6.82% | 2.18% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 1.66 M | $3.26 M | -14.04% | 2.07% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.36 M | $2.67 M | 100.00% | 1.69% |
| SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.33 M | $2.60 M | 0.00% | 1.65% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 1.32 M | $2.59 M | -18.40% | 1.64% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2024 | 1.29 M | $2.53 B | 0.00% | 1.60% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 848,970 | $1.66 M | 100.00% | 1.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 575,899 | $1.13 M | -6.84% | 0.72% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 373,835 | $732,717 | -42.06% | 0.46% |
| UBS OCONNOR LLC | 11/14/2024 | 308,758 | $605,166 | 5.11% | 0.38% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 143,883 | $282,011 | 100.00% | 0.18% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 125,852 | $247,000 | 0.00% | 0.16% |
| STATE STREET CORP | 11/14/2024 | 111,907 | $219,338 | 21.50% | 0.14% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 109,655 | $214,924 | 1.18% | 0.14% |
| MILL CREEK CAPITAL ADVISORS, LLC | 11/06/2024 | 104,631 | $205,077 | 0.00% | 0.13% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 103,405 | $202,674 | 100.00% | 0.13% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 66,000 | $129,360 | 1.23% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 54,211 | $106,254 | 100.00% | 0.07% |
| 11/13/2024 | 52,792 | $103,472 | 100.00% | 0.07% | |
| Y-INTERCEPT (HONG KONG) LTD | 11/15/2024 | 45,635 | $89,445 | 100.00% | 0.06% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 43,200 | $84,672 | 100.00% | 0.05% |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 10/24/2024 | 36,000 | $70,560 | 0.00% | 0.04% |
| CAXTON CORP | 11/14/2024 | 18,403 | $36,071 | 0.00% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 13,844 | $27,134 | 0.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 10,192 | $19,976 | -5.42% | 0.01% |
| CERITY PARTNERS LLC | 11/12/2024 | 10,000 | $19,600 | 100.00% | 0.01% |
| UBS GROUP AG | 11/14/2024 | 1,717 | $3,365 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 500 | $980 | 0.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 10/15/2024 | 200 | $392 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 173 | $339 | 100.00% | 0.00% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
Context Therapeutics Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CNTX shares?
During the previous two years, 47 institutional investors and hedge funds held shares of Context Therapeutics Inc.. The most heavily invested institutionals were:
Deep Track Capital, LP: 7.42 M
Nextech Invest Ltd.: 7.42 M
Avidity Partners Management LP: 7.42 M
GREAT POINT PARTNERS LLC: 6.93 M
Blue Owl Capital Holdings LP: 5.41 M
Blackstone Inc.: 2.44 M
-
What percentage of Context Therapeutics Inc. stock is owned by institutional investors?
70.43% of Context Therapeutics Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CNTX ?
Institutional investors have bought a total of 53.73 M shares in the last 24 months. This purchase volume represents approximately $75.22 M in transactions.